Nicola Mason of the University of Pennsylvania School of Veterinary Medicine develops cancer immunotherapies for dogs that also accelerate novel clinical treatments for human patients. At Penn, many researchers are developing immunotherapies—treatments that stimulate the immune system to fight diseases. Mason says translating those into the clinic can be challenging, but her ability to do this work successfully is due to Penn’s role as place filled with an incredible collaborative spirit. Learn